FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up

Schizophrenia drug Abilify MyCite becomes the first drug approved in the U.S. with a sensor that digitally tracks if patients have ingested their medication. The U.S. Food and Drug Administration on Monday approved Abilify MyCite (aripiprazole tablets with sensor), developed by Otsuka Pharmaceutical Co., Ltd. In Japan, Otsuka Holdings' shares were gaining around 2.7 percent

from RTT - Biotech http://ift.tt/2hrCDPb
via IFTTT